Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA cross-linking refers to the formation of covalent bonds between two nucleotides within DNA, either on the same strand (intrastrand) or between opposite strands (interstrand). This process can be triggered by various exogenous agents (such as chemotherapeutic drugs, UV light, or environmental toxins) or endogenous cellular processes. Cross-links disrupt essential cellular functions like DNA replication and transcription, often leading to cell death if not properly repaired. DNA-protein crosslinks are a related phenomenon where proteins become covalently attached to DNA through similar mechanisms—these are also highly toxic lesions requiring specialized repair systems.
Formation of covalent linkages within/between DNA strands, leading to replication and transcription blockage and subsequent cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA (Cross-linking).